| Trial title (a-z) | Status | Start date | | A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Humanized Anti-CS1 Monoclonal IgG1 Antibody) and Bortezomib in Subjects With Multiple Myeloma Following One to Three Prior Therapies. | Recruiting | 2007-10-01 |
| Topics: Multiple Myeloma |
| Interventions: Drug: Elotuzumab (HuLuc63) |
| View entire trial record on ClinicalTrials.gov: NCT00726869 |
| A Phase 1/2a Study of ABT-263 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia | Recruiting | 2007-06-01 |
| Topics: Chronic Lymphocytic Leukemia |
| Interventions: Drug: ABT-263 |
| View entire trial record on ClinicalTrials.gov: NCT00481091 |
| A Phase 1b Study of MDX-1106 in Subjects With Advanced or Recurrent Malignancies | Recruiting | 2008-10-01 |
| Topics: Metastatic Castration-resistant Prostrate Cancer; Renal Cell Carcinoma; Malignant Melanoma; Non-small Cell Lung Cancer |
| Interventions: Biological: BMS-936558 (MDX-1106); Biological: BMS-936558 (MDX-1106); Biological: BMS-936558 (MDX-1106) |
| View entire trial record on ClinicalTrials.gov: NCT00730639 |
| A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) | Recruiting | 2008-09-01 |
| Topics: Advanced or Metastatic HCC |
| Interventions: Drug: GC33 |
| View entire trial record on ClinicalTrials.gov: NCT00746317 |
| A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer | Recruiting | 2006-12-01 |
| Topics: Solid Tumors; Breast Cancer |
| Interventions: Drug: BEZ235 |
| View entire trial record on ClinicalTrials.gov: NCT00620594 |
| A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer | Recruiting | 2007-12-01 |
| Topics: Solid Tumors; Breast Cancer; Cowden Syndrome |
| Interventions: Drug: BGT226 |
| View entire trial record on ClinicalTrials.gov: NCT00600275 |
| A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma | Recruiting | 2009-01-01 |
| Topics: Nasopharyngeal Carcinoma |
| Interventions: Biological: Epstein-Barr Virus Specific Immunotherapy |
| View entire trial record on ClinicalTrials.gov: NCT00834093 |
| A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas | Recruiting | 2008-04-01 |
| Topics: Neurofibromatosis Type 1 |
| Interventions: Drug: Sirolimus, Rapamycin |
| View entire trial record on ClinicalTrials.gov: NCT00634270 |